Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Oncozyme Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01378143
First received: June 15, 2011
Last updated: October 20, 2014
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)